CSL Falls 1.4% On Average Volume For A Second Consecutive Day, A Two Day Fall of 1.6%

(CSL)
CSL
AUSTRALIA Edition buysellsignals.com | 1 MONTH PRICE VOLUME 3Mo
Thursday, June 14, 2012
5Yr
CSL falls 1.4% on average volume for a second consecutive day, a two day fall of 1.6%
CSL Limited fell 55.0c (or 1.4%) for a second consecutive day on Thursday bringing its two-day fall to 62.0c or 1.6%. Compared with the All Ordinaries index, which fell 21.7 points (or 0.5%) on the day, this was a relative price change of -0.9%.
Shares Outstanding: 510,373,491 Market Cap: $20 billion Closing Price: $39.20
PERCENT R
L-T Rating: 3 out of 5

Price/Earnings ROA ROE Yield % Price/Sales Price/NTA % Disc to High % Prem to Low
CONTENTS
S-T Rating: 3 out of 5

Present Value $1000 (1 year) REL STRENGTH (6M) PEMAP50 30-DAY PRICE (%) 1-YEAR PRICE(%) 3-MONTH PRICE(%) 1-DAY PRICE (%) 5-DAY PRICE (%) 1249 86 1.1 3.4 21.5 16.6 -1.4 -0.5
21.3x 18.6 25.8 2.1 4.6x 7.3x 2.2 50.1
1 Company overview 2 Shareholder returns 3 Stock analysis and ratings
4 Technical analysis 5 Sector ranking 6 News and events
7 Glossary
A publication of:
CSL ( CSL )
buysellsignals.com |
THURSDAY, JUNE 14, 2012
Company Overview
Activities
The CSL Group has a combined heritage of outstanding contribution to medicine and human health with more than 90 years experience in the development and manufacture of vaccines and plasma protein biotherapies. Further details can be found at http://www.csl.com.au/. In the half year to December 31, 2011 total revenue was up 0.5% to $8.1 billion Net profit growth 74.4% to $389 million EPS up 66.7% to 30.0c.
ANNUAL REPORT FOR THE YEAR ENDED JUNE 30, 2011

year-on-year comparisons with previous corresponding period
VOLUME WEIGHTED PRICE
FAVOURABLE CHANGES
Interest cover up 8.8% to 83.7 5-years average annualized earnings growth rate of 23.1% Retained earnings to total assets up 29.4% to 75.2% Total revenue to total assets up 5.3% to 0.9.
UNFAVOURABLE CHANGES
Total revenue down 6.6% to $A4.3b ($US4.6b) Net profit down 10.7% to $A940.6m ($US1.0b) EPS down 5.9% to $A1.74 ($US1.86) EBIT Margin down 7.6% to 29.0% Although the Total Liabilities to Operating Cash Flow ratio of 1.4 compares favourably with the Joseph Piotroski benchmark of <4, it had deteriorated by 9.4% from the previous year. Total liabilities to total assets up 7.7% to 0.3 Current ratio down 31.1% to 2.9 Net tangible assets per share down 12.2% to $A5.05 ($US5.4) Working capital to total assets down 19.8% to 35.8% EBIT to total assets down 2.2% to 23.9%.
RELATIVE STRENGTH
MAJOR COMMON SIZE RATIOS

Total current assets to total assets down from 58.5% to 54.5% Total non-current assets to total assets up from 41.5% to 45.5% Current inventory to total assets up from 25.5% to 28.7% Fixed assets to total assets up from 21.1% to 23.8% Intangibles to total assets up from 16.7% to 18.1% Cost of goods sold to sales up from 47.2% to 49.3% EBIT to Sales down from 30.2% to 28.1% Profit before tax to sales down from 29.8% to 27.7% Profit after tax to sales down from 22.8% to 21.8% Sales and marketing expenses to sales down from 10.6% to 10.2%.
Top Management
The managing director and chief executive officer is Brian Mcnamee and the chairman is John Shine.
Financials Issued Capital

HALF YEARLY REPORT
year-on-year comparisons with previous corresponding period Based on 510,373,491 issued equity shares the market capitalisation is $20 billion. It is Australia's largest Pharmaceuticals, Biotechnology & Life Sciences company by total revenue.
Copyright BuySellSignals Financial Research. Please refer to Disclaimer on back page.
CSL ( CSL ) | Page 2
CSL ( CSL )
Company Overview Cont.

TOP 3 SHAREHOLDERS Name of Shareholder
HSBC Custody Nominees (Australia) Limited J P Morgan Nominees Australia Limited-1 National Nominees Limited
PRESENT VALUE $1000 No. of Shares

123,631,700 84,687,285 58,510,734 266,829,719
3Yr
5Yr
% Held
23.56 16.14 11.15 50.85
Total TOP 20 SHAREHOLDERS
SHAREHOLDER RETURNS(PV $1000)
5Yr
Shareholder Returns
TRAILING ONE WEEK
The stock fell three times (60% of the time) and rose twice (40% of the time). The aggregate volume was 1.0 time average trading of 10,425,420 shares. The value of $1,000 invested a week ago is $1,023 [vs $984 for the All Ordinaries index], for a capital gain of $23(or rise of 2.3%).
TRAILING ONE MONTH

The stock fell eleven times (50% of the time) and rose eleven times (50% of the time). The aggregate volume was 0.9 times average trading of 45,871,848 shares. The value of $1,000 invested a month ago is $1,033 [vs $940 for the All Ordinaries index], for a capital gain of $33(or rise of 3.3%).
TRAILING ONE YEAR

The value of $1,000 invested one year ago is $1,249 [vs $923 for the All Ordinaries index], including a capital gain of $215 and dividend reinvested of $33. The total return to shareholders for 1 year is 24.8%.
TRAILING FIVE YEARS

The value of $1,000 invested five years ago is $1,451, including a capital gain of $302 and dividend reinvested of $149.
CSL ( CSL )
Analysis & Rating (Long-Term & Short-Term)

Long-Term Rating (Fundamentals): 3 out of 5
CSL is ranked number 1 out of 76 listed pharmaceuticals, biotechnology & life sciences companies [that traded today] in Australia with a market capitalization of $20 billion.
Within its sector it has a relatively low P/E of 21.3, low P/S of 4.6. It has a strong relative ROE of 25.8% and ROA of 18.6%. The company paid a dividend of 36.0c in the last twelve months. The dividend yield is high at 2.1%. Stocks are scored on a set of parameters reflecting fundamental analytical tools involving valuation, size and financial performance. They are ranked according to the average values of those parameters. The highest rating is 5 and the lowest rating is 1.
Short-Term Rating (Technical): 3 out of 5

Its short term falls have been combined with weak volume resulting in weak momentum falls over 1, 5 and 30 days.
Significantly its price of $39.20 is at a premium of 21% to its 200-day moving average price of $32.51. Its 52-week range has been $40.06 to $26.12; it is trading at a discount of 2.2 % to its 52-week high and a premium of 50.1 % to its 52-week low. $1,000 invested exactly one year ago is now worth $1,249 of which $215 is a capital gain and $33 is dividends. Recommended stop loss: $36.26 Stocks are scored on a set of technical parameters reflecting price performance and trading volumes. They are ranked according to the average values of those parameters. The highest rating is 5 and the lowest rating is 1.
Relative Valuation Indicators - RVI Technical Analysis

BULLISH SIGNALS:
The price added 3.3% in the last month. In the Australian market of 1,240 stocks and 59 units traded today, the stock has a 6-month relative strength of 86 which means it is beating 86% of the market. The price to 50-day EMAP ratio is 1.1, a bullish indicator. In the past 50 days this ratio has exceeded 1.1 24 times suggesting further upside. The 50-day EMAP has increased to $37.13. An increase is another bullish indicator. The Moving Average Convergence Divergence (MACD) indicator of 12-day Exponential Moving Average (EMA) of 38.7 minus the 26-day EMA of 38.1 is positive suggesting a bullish signal. Both the 12-day EMA as well as the 26-day EMA are rising, another bullish signal. In the last three months the stock has hit a new 52-week high ten times, pointing to a significant uptrend. The price to 200-day MAP ratio is 1.21, a bullish indicator. In the past 200 days this ratio has exceeded 1.21 five times suggesting further upside. The stock is trading above both its MAPs and the 50-day MAP of $37.34 is higher than the 200-day MAP of $32.51, another bullish indicator.
Relative Valuation Indicators - RVI Fundamental Analysis

THE STOCK MEETS THE FOLLOWING VALUE CRITERION SET BY BENJAMIN GRAHAM:
"Current ratio of two or more"; current assets are 2.92 times current liabilities. "Stability of growth in earnings over the last 5 years, defined as no more than two declines of 5% or greater in year-end earnings"; there has been 1 decline in earnings in the last 5 years.
THE STOCK HAS A SCORE OF 6 OUT OF 9 SET BY JOSEPH PIOTROSKI [PASS MARK >=5 ]:
Positive net income; Positive operating cashflow; Return on assets improvement [from 18.4% to 18.6%]; Good quality of earnings [operating cashflow exceeds net income]; Improvement in longterm debt to total assets from 0.08 to 0.04; Reduction in total shares on issue.
BEARISH SIGNALS:
The Stochastic indicator of 88.5 has broken through the overbought line of 80.
CSL ( CSL )
Analysis & Rating (Long-Term & Short-Term) Cont.

Short Selling Trend
Code
CSL
Short Volume
337,081
Avg. Daily Volume

2,077,474
Days to Cover (Short Volume/Avg. Daily Volume): 0.1 days Short Sell (percent of issued shares): 0.1% Bullish Indicators: The current short volume is 0.8 times its own historical average of 0.1%. It crashed 37.1% from the previous day, crashed 23.7% from a week ago, a bullish indicator. Bearish Indicators: In the Australian Short Selling market of 422 stocks, short selling as a % of issued shares ranked 68th and within the top quartile of stocks. This means it was higher than market average of 0.05%, a bearish indicator.
CSL ( CSL )
Technical Analysis
Price Dynamics
VOLATILITY
The stock traded between an intraday high of $39.98 and a three-day low of $39.09, suggesting a trading opportunity between peaks and troughs. The average daily volatility of 2.0% places the stock in the 4th quartile in the market meaning it is least volatile.
BETA
The Beta of this stock is 0.64. A Beta lower than 1 suggests this is a low risk, low return stock with volatility less than that of the market.
STANDARD DEVIATION (SD)

SD is a statistical measure of deviation from the mean. The SD of 1.5% gives it a percentile rank of 5 meaning that 5% of stocks in the Australian market are less volatile than this stock.
% DISCOUNT TO HIGH
The last price is at a discount of 2.2% to the 12-month high of $40.06 one-day ago on 13 Jun, 2012.
TRAILING MONTH
In the last 16 trading sessions there has been a net rise of 5.8%; the stock has advanced eleven times and the biggest one day rise was 1.6% on May 24.
ONE-YEAR PRICE HIGH, CLOSE AND LOW PRICE
5Yr
Aggregate Volumes, Prices And Turnover Period

[Volume Index or VI in brackets; 1 is average] Australian Securities Exchange: CSL.AU 1,902,469 [VI of 0.9]; volume 99.83% of aggregate. Price: $39.20. OTC Pink: CMXHF.PK 3,181 [VI of 2.4]; volume 0.17% of aggregate. Price: US$39.30. Using the current exchange rate of USD1 equals 1.0081AUD, the shares are at a 1.1% premium to the close price in the Australian Stock Exchange. Aggregate volume: there were 1,905,650 shares worth $75.3 million traded. The aggregate volume was 0.9 times average trading of 2,086,435 shares.
% DISCOUNT TO HIGH AND % PREMIUM TO LOW
VOLUME WEIGHTED PRICE (VWP)

The price is at a premium of 3.3% to the 1-month volume weighted average price of $37.94. Given that this premium has been under 3.3% eighty-four times and over 3.3% seventy times in the last year, the downside:upside probability is estimated at 84:70 or 1.2:1.
RISES TO FALLS
In the last three months the number of rises outnumbered falls 34:29 or 1.2:1.
CSL ( CSL )
Technical Analysis Cont.

Open Interest Trend And Interpretation
Open interest hit an 11-day high.
Top 3 Put Options

Top three traded put options [1 contract is 100 shares]
EXERCISE $37.0; EXPIRES JUN 28
10.0c down 16.7%; volume 195; open interest 1490
SAME DAY TREND

Open interest advanced for a tenth straight day; the stock fell for a second day. Open interest increased 1.9% from 132,255 to 134,725. Combined with the price falling 1.4% this suggests the market is weak.

78.0c down 16.1%; volume 160; open interest 130
TRAILING ONE WEEK TREND

Open interest rose for a second week. Open interest surged 9.5% from 123,027 a week ago while the stock dipped 0.5% from $38.33 a week ago. Combined with the decrease of price this also suggests the market is weak.
EXERCISE $39.0; EXPIRES AUG 30

$1.31 up 8.7%; volume 5; open interest 44
TRAILING ONE MONTH TREND

Open interest jumped 7.5% from 125,296 a month ago while the stock added 3.3% from $37.97 a month ago. Combined with the rising price this suggests the market is strong.
OPEN INTEREST TREND
OPEN INTEREST AS % OF ISSUED CAPITAL

13,472,500 shares, representing 2.6% of the issued capital. [ranked 15 out of 67 stocks in descending order]
2012 OPEN INTEREST

131,786 contracts, representing 97.8% of total.
2013 TO 2014 OPEN INTEREST

2,939 contracts, representing 2.2% of total.
PUT:CALL RATIO
Open interest contracts on exchange traded options included 46,108 put contracts and 88,617 call contracts. The put:call ratio was 0.5, up 0.4% for the day, up 10.9% in the past week and down 6.6% in the past month.
Top 3 Call Options

Top three traded call options [1 contract is 100 shares]
73.0c up 4.3%; volume 224; open interest 2409
EXERCISE $41.0; EXPIRES JUL 26

82.0c up 32.3%; volume 5; open interest 878
EXERCISE $41.0; EXPIRES AUG 30

$1.33 up 8.1%; volume 5; open interest 39
CSL ( CSL )
Sector Ranking
Market Share
CSL vs Pharmaceuticals, Biotechnology & Life Sciences sector [Pharmaceuticals, Biotechnology & Life Sciences sector Total in Brackets] Revenue of $4.3 billion[55.2% of aggregate sector revenue of $7.8 billion; down from 57.5% in the previous year.] EBIT of $1.2 billion [98.6% of aggregate sector EBIT of $1.2 billion; down from 109.1% in the previous year.]
BuySellSignals Sector Valuation Table

TOTAL AUSTRALIAN MARKET Fundamental Valuation
P/Earnings Price/Net Tangible Assets 2.3x Discount to 52-Wk High (%) 15.95 Premium to 52-Wk Low (%) 13.4
Price Performance Rank

The stock is in 10 indices and 2 sectors.
Total Australian Market Avg CSL Rank Rank 1 Rank 2 Rank 3 Lowest Rank
14.1x
THE FOLLOWING INDEX AND SECTORS FELL SETTING THE TREND FOR ITS FALL OF 1.4%:
Pharmaceuticals, Biotechnology & Life Sciences sector of 52 stocks traded today, which was down 95.2 points or 1.6% to 5,820.0, All Ordinaries index of 428 stocks and 38 units traded today, which was down 21.7 points or 0.5% to 4,089.8, The Total Australian Market of 1240 stocks and 59 units traded today, which was down 21.2 points or 0.5% to 4,274.6
21.3x 375 1.6x IRC 1.6x MDL 1.7x RHG
7.3x 1037 0.1x BSM 0.1x BMG 0.1x DMX
2.2 1618 97.6 MBT 96.6 DMX 96 MDV 0.2 ONT
50.1 1118 0.2 TRU 0.4 IPL 0.4 IMF
Stock Ranking by Percentage Price Change, versus Index and Sectors for 1 day and 6 months
Total Rank of Rank of Number of Stock Stock Stocks in 6 1 Day Months Sector/Inde x
Pharmaceuticals, Biotechnology & Life Sciences sector All Ordinaries index Total Australian Market 34 9 74
Size
Market Cap $ Total Australian Market Avg CSL Rank 1B 20 B 12 175.2 B BHP 106.4 B RIO 80 B CBA 562,731 KME
336 875
45 173
487 1839
Rank 1 Rank 2 Rank 3 Lowest Rank
CSL ( CSL )
buysellsignals.net |
Sector Ranking Count

Performance
Yield (%) Total Australian Market Avg CSL Rank Rank 1 Rank 2 Rank 3 Lowest Rank 4.9 2.1 407 17.2 SYM 16.4 CLT 15.4 GLB 0.03 AGF Free Cash Flow 45.8 million 819.6 M 11 19.1 B BHP 18.5 B ANZ 17.2 B CBA
Technicals Price Volume Dynamics

PV $1,000 (1 Yr) Total Australia n Market Avg CSL Rank Rank 1 887.9 Rel Hits(3m) PEMAP5 1-Day 5-Day 30-Day 3-Month 1-Year 30-Day Strength 52-W Hi 0 Price (%) Price (%) Price (%) Price (%) Price (%) Avg (6m) Volatilit y 72.7 -0.5 -1.5 -6.7 -6.96 -15.1 1.7 Moment um
1,248.5 155 29,250.0 SYR 18,125.0 AXM 8,000.0 MAC 24.3 MBT
86.01 173 99.9 AXM 99.8 SYR 99.8 MAD 0.1 MBT
10 45 36 MFF 23 AMH 22 APE 1 BYL
1.1x 78 1.5x SYR 1.5x EXM 1.4x SUR 0.2x MBT
-1.4 875
-0.5 469
3.3 205
16.6 83
21.5 142
2.2 886 100 RAU LMB 100 MST AIQ 524
Rank 2
Rank 3
50 ISN -50 GDA -50 KIK
92.9 GDA RFE 0.2 VTA ZRL

Lowest Rank
CSL ( CSL )
Financial Results
Year-on-year Comparisons
INTERIM REPORT (HALF YEAR): CSL (ASX:CSL) EPS UP 66.67% TO $A0.3

Summary
GENERAL INFORMATION
Company Name Company ISIN Company CODE Industry CSL Limited AU000000CSL8 CSL Pharmaceuticals, Biotechnology & Life Sciences sector
CSL ( CSL )
Financial Results Cont.

INCOME STATEMENT
Currency in Million of AUD Revenue Insurance premium income Reinsurance and other recoveries income Banking interest income 4,093 1,147 2,088 7,328 Investment revenue Other income 467 312 779 Total revenue Expenses General insurance claims expense -3,871 -3,044 -584 -380 1,798 -230 -1,342 -213 -106 -8 -7,601 506 116 390 -3 -7,700 364 137 227 Deterioration 166.7 Reduced 1.3 Up 39.0 Down 15.3 Up 71.8 Deterioration 27.2 Recovery Deterioration 18.2 Down 8.4 Deterioration 4.8 Reduced 4.6 Reduced 38.5 8,107 3,945 857 2,213 7,015 713 336 1,049 8,064 Up 3.8 Up 33.8 Down 5.6 Up 4.5 Down 34.5 Down 7.1 Down 25.7 Up 0.5 2011-12-31 2010-12-31 Change %
Life insurance claims expense and movement in policyowner 26 liabilities Outwards reinsurance premium expense Interest expense Fees and commissions expense Operating expenses Impairment expense Fair value remeasurement of assets and liabilities classified as held for sale Outside beneficial interests in managed funds Total expenses Profit before income tax Income tax expense Profit for the period Other comprehensive income Net change in fair value of cash flow hedges Net change in fair value of available-for-sale financial assets Exchange differences on translation of foreign operations Income tax expense on other comprehensive income Other comprehensive income net of income tax Total comprehensive income for the period Profit for the period attributable to: Owners of the Company Non-controlling interests 389 1 60 -66 -12 2 -16 374 -449 1,647 -241 -1,280 -131
70 -4 -51 -21 -6 221
Down 14.3 Deterioration 1,550.0 Reduced 76.5 Recovery Deterioration 166.7 Up 69.2
223 4
Up 74.4 Down 75.0
CSL ( CSL )

Profit for the period Total comprehensive income for the period attributable to: Owners of the Company Non-controlling interests Total comprehensive income for the period Earnings per share: Basic earnings per share Diluted earnings per share TSO 30.0c 30.0c 1,286,600,980 18.0c 18.0c 1,281,390,524 Up 66.7 Up 66.7 Up 0.4 373 1 374 217 4 221 Up 71.9 Down 75.0 Up 69.2 390 227 Up 71.8
CSL ( CSL )

BALANCE SHEET
Currency in Million of AUD Assets Cash and cash equivalents Receivables due from other banks Trading securities Derivatives Investment securities Assets classified as held for sale Banking loans, advances and other receivables General insurance assets Life assets Property, plant and equipment Deferred tax assets Other assets Goodwill and intangible assets Total assets Liabilities Deposits and short-term borrowings Derivatives Payables due to other banks Payables and other liabilities Current tax liabilities Liabilities classified as held for sale General insurance liabilities Life liabilities Deferred tax liabilities Managed funds units on issue Securitisation liabilities Debt issues Subordinated notes Preference shares Total liabilities Net assets Equity Share capital Reserves Retained profits Total equity attributable to owners of the Company Non-controlling interests 12,665 36 1,420 14,121 12 12,614 4 1,273 13,891 21 Up 0.4 Up 800.0 Up 11.5 Up 1.7 Down 42.9 365 4,313 8,676 1,368 760 78,872 14,133 14,956 5,770 38,774 2,105 26 1,752 7 36,855 3,266 18 1,528 171 12 11,866 6,268 3 581 4,011 12,680 1,814 871 79,944 13,912 Down 37.2 Up 7.5 Down 31.6 Down 24.6 Down 12.7 Down 1.3 Up 1.6 Up 26.0 Down 7.9 Up 5.2 Down 35.5 Up 44.4 Up 14.7 Down 95.9 47,739 7,247 586 230 94 717 6,295 93,005 1,231 159 3,641 291 24,775 1,496 91 4,868 376 23,969 118 50,351 4,506 538 337 170 668 6,368 93,856 Down 5.2 Up 60.8 Up 8.9 Down 31.8 Down 44.7 Up 7.3 Down 1.1 Down 0.9 Down 17.7 Up 74.7 Down 25.2 Down 22.6 Up 3.4 2011-12-31 2010-12-31 Change %
CSL ( CSL )

Total equity 14,133 13,912 Up 1.6
PERFORMANCE RATIOS
2011-12-31 Return on Equity(%) 2.75 2010-12-31 1.6 Change % Up 71.7
PER SHARE FIGURES

2011-12-31 EPS EPS Dilution Factor 30.0c 0.9 USD Conversion at balance date of December 31,2011 Export in XLS 2010-12-31 18.0c Change % Up 66.7
CSL ( CSL )
News and Events

Reported Buying Selling
May 04: CSL director buys
CSL (CSL.AU) director Christine OReilly bought 541 shares worth approximately $20,033.2 on February 10, 2011. Christine OReilly previously held 642 shares and now holds 1,183 shares. The purchase price was $37.0. Date Name
RECENT SUBSTANTIAL SHAREHOLDER SELLING

No. of Shares Shares No. of Held Shares At Price Previous Close ly
February 28: CSL director buys

CSL (CSL.AU) director Ian Renard bought 267 shares worth approximately $8,784.3 on February 24, 2012. Ian Renard previously held 18,408 shares and now holds 18,675 shares. The purchase price was $32.90.
220334,827,6 28,713,89 2011 Capital Group 6,113,796 95 $34. 9 shares , 01- Companies Inc shares shares 05 (5.4709%) 07(6.496%) 2011
February 24: CSL director buys

CSL (CSL.AU) director John Akehurst bought 270 shares worth $8,663 on February 23, 2012. John Akehurst previously held 30,353 shares and now holds 30,623 shares. The purchase price was $32.10.
RECENT DIRECTOR BUYING

Date Name No. of Shares Shares No. of Held Shares At Price Previous Close ly 642 shares 18,408 shares 1,183 shares 18,675 shares $37. 03 $32. 90
February 14: CSL substantial shareholder buys

CSL (CSL.AU) substantial shareholder Commonwealth Bank of Australia and Its Subsidiaries bought 3,959,714 shares worth approximately $122 million between January 21, 2011 and February 09, 2012. Commonwealth Bank of Australia and Its Subsidiaries previously held 27,290,067 shares (or 5.0%) and now holds 31,249,781 shares (or 6.0%). The purchase price was $30.80.
10022011 24022012
Christine OReilly
541 shares 267 shares
Ian Renard
RECENT DIRECTOR SELLING

Date Name No. of Shares Shares No. of Held Shares At Price Previous Close ly 167,196 shares 122,196 shares $29. 33
November 04: CSL director sells

CSL (CSL.AU) director Peter Turner sold 45,000 shares worth approximately $1.3 million on November 04, 2011. Peter Turner previously held 167,196 shares and now holds 122,196 shares. The selling price was $29.50.
04112011
Peter Turner
45,000 shares
RECENT SUBSTANTIAL SHAREHOLDER BUYING

Date Name No. of Shares Shares No. of Held Shares At Price Previous Close ly
Company Announcements:Recent Headlines and Snippets

THE LAST 15 SNIPPETS WERE:
June 13, 2012: CSL buys back 75,134 shares

CSL (CSL.AU) announced a buyback of 75,134 shares worth $2,984,367.56 on June 12, 2012. Open Full Announcement.
2101- Commonwealth 27,290,0 net 31,249,78 2011 Bank of 67 $36. 3,959,714 1 shares , 09- Australia and shares 94 shares (6.02%) 02- Its Subsidiaries (5.01%) 2012

CSL ( CSL )
News and Events Cont.

CSL (CSL.AU) announced a buyback of 21,348 shares worth $822,414.62 on June 06, 2012. Open Full Announcement.


CSL (CSL.AU) announced a buyback of 9,801 shares worth $366,114.39 on June 01, 2012. Open Full Announcement.

CSL (CSL.AU) announced a buyback of 3,716 shares worth $137,049.80 on May 31, 2012. Open Full Announcement.
May 31, 2012: CSL buys back 157,919 shares

CSL (CSL.AU) announced a buyback of 157,919 shares worth $5,813,582.69 on May 30, 2012. Open Full Announcement.
May 31, 2012: CSL: Form 484 - Change in Share Structure

[Company Release] http://www.asx.com.au/asx/statistics/displayAnnouncement.d odisplay=pdf&idsId=01301909 Open Full Announcement.

CSL (CSL.AU) announced a buyback of 241,000 shares worth $8,884,224 on May 29, 2012. Open Full Announcement.


CSL (CSL.AU) announced a buyback of 250,000 shares worth $9,299,200 on May 25, 2012. Open Full Announcement.
May 28, 2012: CSL: Appendix 3B

[Company Release] http://www.asx.com.au/asx/statistics/displayAnnouncement.d odisplay=pdf&idsId=01300915 Open Full Announcement.



CSL ( CSL )
Glossary
DEBT/EQUITY
Net Debt/Net Assets (times) Dividends received during the Period
TOTAL PROFIT (LOSS) OVER N YEARS (3/2/1)

Capitla Gain (Loss) plus Dividens received minus Original Investment
CURRENT RATIO
Current Assets/Current Liabiliites (times)
INTEREST COVER
Earnings Before Interest and Tax/Interest (times)
TOTAL LIABILITIES/TOTAL ASSETS

Total Liabilities/Total Assets
EARNINGS YIELD ACTUAL

Earnings Per Share/Share Price (%)
FREE CASH FLOW PER SHARE

Earnings Before Interest, Tax, Depreciation and Amortisation Minus Capex/Per Share
EBIT MARGIN
Earnings Before Interest and Tax/Revenue (%)
CAPITAL GAIN/LOSS FROM N YEARS AGO TO N-1 YEARS AGO

Capital Gain or Loss over 1 Year/Price 1 Year Ago (%)
RETURN ON ASSETS
Net Profit/Total Assets (%)
ANNUAL RETURN
Dividends Paid In a 12-Month Period/Price at the Beginning of the Period + Capital Gain or Loss over 1 Year/Price 1 Year Ago (%)
PRICE/EARNINGS
Share Price/Earnings Per Share (times)
PRICE/SALES PS
Share Price/Sales Per Share (times)
BANKS COST-TO-INCOME RATIO OR EFFICIENCY RATIO

Total Non-Interest Expense/Total Income (Net Interest Income + Non-Interest Income)
PRICE/NTA
Closing Share Price/Net Tangible Assets Per Share (times)
BANKS NON-INTEREST INCOME TO TOTAL INCOME

Non-Interest Income (Loan fees etc)/Total Income (Net Interest Income + Non-Interest Income)
CASH/MCAP
Cash plus Liquids/Market Capitalisation (times)
VOLUME INDEX
Number of shares traded in the period/Average number of shares traded for the period
BANKS TIER 1 RATIO

Tier 1 Capital (Ending Equity - Intangibles etc)/Total Tangible Assets
MOVING AVERAGE PRICE (N PERIODS)

Sum of Prices for each Period/Number of Periods
BANKS TIER 2 RATIO

Tier 2 Capital (Tier 1 - Subordinated Debt + Unrealised Gains/Loan Losses)/Total Tangible Assets
PRICE CLOSE/MOVING AV PRICE

Latest Price/Moving Average Price
NET INTEREST MARGIN

Net Interest Income/Average of all Earning Assets
DIVIDEND YIELD
Dividend Per Share/Share Price (%)
RETURN ON EQUITY (SHAREHOLDERS' FUNDS)

Net Profit/Net Assets (%)
DIVIDEND % FRANKED (A)

Dividend Per Share Franked/Dividend Per Share (%)
DIVIDEND PAYOUT RATIO

Dividend Per Share/Earnings Per Share (%)
CAPITAL PROFIT (LOSS) N YEARS AGO (3/2/1)

Value of Current Investment minus Value of Original Investment
INCOME DURING THE N YEARS (3/2/1)

BuySellSignals Financial Research provides equity research on over 42,000 companies listed in more than 80 countries across the world. BuySellSignals believes that every stock has a story to tell and that this story changes every day. To capture this story, BuySellSignals offers the latest pertinent and comprehensive information so that investors can make well-informed investment decisions.
BuySellSignals publishes equity research reports on each stock, sector and index daily to capture the latest market movements and sentiments. BuySellSignals eschews hot tip or headline investing in favour of high-quality, ultra-current, targeted technical and fundamental information including specific bullish and bearish signals for each stock. Insights that will guide you to the investments that are hard to find in todays hyperactive mainstream markets. Further details on definitions and quotations from investing legends can be found in following link: http://buyselltips.net/PressClipping/DefinationOfVariable.php.
BST MOMENTUM COLOUR GUIDE Momentum Up Weak Momentum Up Momentum Down Weak Momentum Down Strong Unchanged Weak Unchanged Untraded
Price increase fuelled by above average Volume Price increase on below average Volume Price decrease fuelled by above average Volume Price decrease on below average Volume Price unchanged on above average Volume Price unchanged on below average Volume Untraded
Disclaimer: While this document is based on information sources which are considered reliable, it has been prepared without consideration of your specific investment objectives, financial situation or needs, so you should carry out your own analysis or seek professional investment advice before an investment decision is made. The document contains unbiased, independent equities data from BuySellSignals (AFS Licence 222756) and News Bites Pty Ltd, who provide round the clock data on every Australian stock and sector. Neither BuySellSignals nor News Bites are brokers, and neither have an executing, corporate advisory or investment banking function. BuySellSignals and News Bites Pty Ltd, its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. The data is sourced from annual reports and company releases and may not be fully up to date. It should be used as a guide only.
Copyright BuySellSignals Financial Research. Please refer to Disclaimer at cover page.

CSL Falls 1.4% On Average Volume For A Second Consecutive Day, A Two Day Fall of 1.6%

Caricato da

Informazioni sul documento

Descrizione originale:

Titolo originale

Copyright

Formati disponibili

Condividi questo documento

Condividi o incorpora il documento

Opzioni di condivisione

Hai trovato utile questo documento?

Questo contenuto è inappropriato?

Copyright:

Formati disponibili

CSL Falls 1.4% On Average Volume For A Second Consecutive Day, A Two Day Fall of 1.6%

Caricato da

Copyright:

Formati disponibili

(CSL)

L-T Rating: 3 out of 5

S-T Rating: 3 out of 5

21.3x 18.6 25.8 2.1 4.6x 7.3x 2.2 50.1

1 Company overview 2 Shareholder returns 3 Stock analysis and ratings

4 Technical analysis 5 Sector ranking 6 News and events

THURSDAY, JUNE 14, 2012

ANNUAL REPORT FOR THE YEAR ENDED JUNE 30, 2011

VOLUME WEIGHTED PRICE

MAJOR COMMON SIZE RATIOS

Financials Issued Capital

Copyright BuySellSignals Financial Research. Please refer to Disclaimer on back page.

CSL ( CSL ) | Page 2

THURSDAY, JUNE 14, 2012

Company Overview Cont.

PRESENT VALUE $1000 No. of Shares

Total TOP 20 SHAREHOLDERS

SHAREHOLDER RETURNS(PV $1000)

TRAILING ONE MONTH

TRAILING ONE YEAR

TRAILING FIVE YEARS

Copyright BuySellSignals Financial Research. Please refer to Disclaimer on back page.

CSL ( CSL ) | Page 3

THURSDAY, JUNE 14, 2012

Analysis & Rating (Long-Term & Short-Term)

Short-Term Rating (Technical): 3 out of 5

Relative Valuation Indicators - RVI Technical Analysis

Relative Valuation Indicators - RVI Fundamental Analysis

Copyright BuySellSignals Financial Research. Please refer to Disclaimer on back page.

CSL ( CSL ) | Page 4

THURSDAY, JUNE 14, 2012

Analysis & Rating (Long-Term & Short-Term) Cont.

Avg. Daily Volume

Copyright BuySellSignals Financial Research. Please refer to Disclaimer on back page.

CSL ( CSL ) | Page 5

THURSDAY, JUNE 14, 2012

STANDARD DEVIATION (SD)

ONE-YEAR PRICE HIGH, CLOSE AND LOW PRICE

Aggregate Volumes, Prices And Turnover Period

% DISCOUNT TO HIGH AND % PREMIUM TO LOW

VOLUME WEIGHTED PRICE (VWP)

Copyright BuySellSignals Financial Research. Please refer to Disclaimer on back page.

CSL ( CSL ) | Page 6

THURSDAY, JUNE 14, 2012

Technical Analysis Cont.

Top 3 Put Options

SAME DAY TREND

EXERCISE $40.0; EXPIRES JUN 28

TRAILING ONE WEEK TREND

EXERCISE $39.0; EXPIRES AUG 30

TRAILING ONE MONTH TREND

OPEN INTEREST TREND

OPEN INTEREST AS % OF ISSUED CAPITAL

2012 OPEN INTEREST

2013 TO 2014 OPEN INTEREST

Top 3 Call Options

EXERCISE $41.0; EXPIRES JUL 26

EXERCISE $41.0; EXPIRES AUG 30

Copyright BuySellSignals Financial Research. Please refer to Disclaimer on back page.

CSL ( CSL ) | Page 7

THURSDAY, JUNE 14, 2012

BuySellSignals Sector Valuation Table